Massachusetts 2025-2026 Regular Session

Massachusetts Senate Bill S2599

Introduced
7/17/25  
Refer
7/17/25  

Caption

Providing insurance coverage for the medically necessary treatment of port-wine stains

Impact

The proposed legislation would amend Chapter 175 of the General Laws to require insurance policies to cover treatments for port-wine stains for individuals aged 18 and younger. This aligns the state’s health insurance offerings with a growing recognition of the necessity of medical versus cosmetic interventions. Importantly, the bill states that coverage cannot impose stricter terms than those applied to other medically necessary services, effectively reinforcing the significance of equal treatment within insurance plans. This could lead to more equitable healthcare access for affected individuals across Massachusetts.

Summary

Senate Bill S2599 aims to mandate insurance coverage for the medically necessary treatment of port-wine stains, a type of capillary malformation skin condition that can lead to significant functional impairments and psychosocial distress, particularly in pediatric patients. The bill establishes definitions for 'medically necessary treatment' and details what constitutes early intervention treatments, such as FDA-approved laser treatments and surgeries. By ensuring coverage for medical treatments that prevent health complications, S2599 seeks to alleviate not only the physical health burden but also the psychological impacts these conditions often impose on children and their families.

Contention

As with many healthcare-related bills, S2599 may face contention regarding the scope of mandated coverage and potential financial implications for insurance providers. Critics could argue about the financial burden this mandate may impose on insurers and how it might affect premiums for the broader population. Additionally, there may be debates on defining what constitutes 'medically necessary' treatment versus cosmetic procedure, particularly in the context of insurance coverage. The bill includes provisions for a review of the mandate’s impact by the Center for Health Information and Analysis, indicating that the legislature anticipates concerns and seeks to address them through data-driven assessments.

Companion Bills

No companion bills found.

Previously Filed As

MA H1039

Providing insurance coverage for Alfi’s syndrome

MA S716

Providing health insurance coverage for scalp and facial hair prostheses

MA H1015

Providing for certain health insurance coverage

MA H137

Providing for insurance coverage for vision screening for children

MA H5143

Relative to treatments and coverage for substance use disorder and recovery coach licensure

MA H4758

Relative to treatments and coverage for substance use disorder and recovery coach licensure

MA H1066

Providing health insurance coverage for scalp and facial hair prosthesis

MA H4743

Relative to treatments and coverage for substance use disorder and recovery coach licensure

MA S658

Relative to dual diagnosis treatment coverage

MA H1141

Relative to dual diagnosis treatment coverage

Similar Bills

CA AB395

Substance use treatment providers.

AZ HB2745

Court-ordered treatment; enhanced services

AZ SB1310

Court-ordered treatment; enhanced services.

AZ HB2944

Inpatient treatment days; computation; exclusion

CA SB349

California Ethical Treatment for Persons with Substance Use Disorder Act.

AZ HB2041

Mental health; voluntary evaluations; payment

CA AB1230

Gambling disorder prevention.

IA HF574

A bill for an act establishing a veterans recovery pilot program and fund for the reimbursement of expenses related to providing hyperbaric oxygen treatment to eligible veterans.(Formerly HF 479.)